ADC Therapeutics
ADCT
ADCT
51 hedge funds and large institutions have $1.01B invested in ADC Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 52 → 51 (-1)
63% less call options, than puts
Call options by funds: $227K | Put options by funds: $611K
Holders
51
Holding in Top 10
4
Calls
$227K
Puts
$611K
Top Buyers
| 1 | +$39.9M | |
| 2 | +$28.8M | |
| 3 | +$16.1M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$15.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$13M |
Top Sellers
| 1 | -$48.4M | |
| 2 | -$9.9M | |
| 3 | -$8.62M | |
| 4 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$6.45M |
| 5 |
IM
Islet Management
New York
|
-$6.2M |